Skip to main content

NIH Launches Web Service to Connect Inventors With Commercial Partners

NEW YORK (GenomeWeb News) — The National Institutes of Health has started a web-based program designed to connect NIH licensees and grant awardees to potential commercialization partners, the NIH said Wednesday.
 
The NIH Pipeline to Partnerships initiative, known as P2P, is designed to enable licensees and awardees, especially early-stage developers, to “showcase their technologies and product development for an audience of potential strategic partners, investors, and licensees,” NIH said.
 
"In the last decade, many successful biomedical products have come from pharmaceutical and biotechnology companies that licensed early-stage technologies from NIH," said Mark Rohrbaugh, director of the NIH’s Office of Technology Transfer, which helped develop the initiative with the NIH Small Business Innovation Research and Small Business Technology Transfer programs.
 
"Faced with less demand for early-stage technologies, this pipeline provides an avenue for potential partners to find NIH licensees along the spectrum of product development to share costs, infrastructure, and expertise as the research and development progresses to later stage clinical trials," he added.
 
The NIH said researchers can view the pipeline of technologies, searchable by category and stage, on OTT’s website.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.